Helping patients quit smoking during lung cancer screening
Official title: Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
Funded at Georgetown University · NIH-11070301 · Data updated 2026-11-12
This study is looking at how well smoking cessation support works for people getting screened for lung cancer, especially for those from diverse backgrounds, to help them quit smoking more easily.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $646,635 |
| NIH project number | 5R01CA274716-03 |
| Project ID | NIH-11070301 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are scheduled for lung cancer screening and currently smoke.
✕Less likely to help
Patients who do not smoke or are not undergoing lung cancer screening may not receive any benefit from this research.
What this research studies
This research investigates the effectiveness of providing smoking cessation treatments to patients who are undergoing lung cancer screening. It aims to address barriers that prevent patients, especially those from diverse and underserved backgrounds, from receiving these treatments. By conducting a randomized trial at multiple lung screening sites within the MedStar Health system, the study will compare two evidence-based cessation methods and implement strategies to enhance patient engagement. The goal is to improve the integration of cessation support into routine lung cancer screening practices.
Why it matters
Potential benefit: If successful, this research could significantly reduce lung cancer deaths and improve the quality of life for patients by increasing smoking cessation rates.
How similar studies have gone: Previous research has shown that integrating smoking cessation support into cancer screening programs can lead to improved patient outcomes, indicating a promising approach.
Where this research is happening
-
Georgetown University
Washington, United States Active
Researchers
- Principal investigator: Taylor, Kathryn L — Georgetown University
- Study coordinator: Taylor, Kathryn L
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.